Works matching IS 0344-5704 AND VI 66 AND IP 3 AND DT 2010

Results: 24

The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 493, doi. 10.1007/s00280-009-1186-3

By:

Jun Liang;
Tao Jiang;
Ru-yong Yao;
Zi-min Liu;
Hong-ying Lv;
Wei-wei Qi

Publication type:

Article

A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 441, doi. 10.1007/s00280-009-1179-2

By:

Chiorean, E. Gabriela;
Malireddy, Srikar;
Younger, Anne E.;
Jones, David R.;
Waddell, Mary-Jane;
Sloop, Melissa I.;
Menggang Yu;
Hall, Stephen D.;
Schneider, Bryan;
Sweeney, Christopher J.

Publication type:

Article

GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 433, doi. 10.1007/s00280-009-1177-4

By:

Yan Liu;
Ke-Ming Xie;
Guo-Qing Yang;
Xiao-Ming Bai;
Yuan-Ping Shi;
Hui-Jun Mu;
Wei-Zhen Qiao;
Bin Zhang;
Ping Xie

Publication type:

Article

Phase II study of carboplatin combined with weekly docetaxel in patients with advanced non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 449, doi. 10.1007/s00280-009-1180-9

By:

Lian Jiang;
Dao-yuan Wang;
Zhi-hua Zhu;
Liang-fa Tang;
Xin-heng Hou;
Hong-da Zhao;
Zheng Xie;
Dan-feng Wang

Publication type:

Article

Differential apoptotic response of human cancer cells to organoselenium compounds.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 475, doi. 10.1007/s00280-009-1183-6

By:

Suzuki, Maiko;
Endo, Manabu;
Shinohara, Fumiaki;
Echigo, Seishi;
Rikiishi, Hidemi

Publication type:

Article

DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 485, doi. 10.1007/s00280-009-1184-5

By:

Hedeland, Rikke L.;
Hvidt, Kristian;
Nersting, Jacob;
Rosthøj, Susanne;
Dalhoff, Kim;
Lausen, Birgitte;
Schmiegelow, Kjeld

Publication type:

Article

Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 507, doi. 10.1007/s00280-009-1190-7

By:

Yeon Hee Park;
Soohyeon Lee;
Eun Yoon Cho;
Yoon La Choi;
Jeong Eon Lee;
Seok Jin Nam;
Jung-Hyun Yang;
Jin Seok Ahn;
Young-Hyuck Im

Publication type:

Article

Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: implication in oxidative stress.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 517, doi. 10.1007/s00280-009-1192-5

By:

Matsunaga, Toshiyuki;
Tsuji, Yoshitaka;
Kaai, Kairyu;
Kohno, Saki;
Hirayama, Renzo;
Alpers, David H.;
Komoda, Tsugikazu;
Hara, Akira

Publication type:

Article

Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 467, doi. 10.1007/s00280-009-1182-7

By:

Liangao Hu;
Weimin Miao;
Loignon, Martin;
Kandouz, Mustapha;
Batist, Gerald

Publication type:

Article

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 425, doi. 10.1007/s00280-009-1176-5

By:

Yong Wha Moon;
Joo Hyuk Sohn;
Hye Jin Choi;
Hyun Chang;
Byeong-Woo Park;
Seung Il Kim;
Seho Park;
Ja Seung Koo;
Yong Tai Kim;
Jae Kyung Roh;
Hyun Cheol Chung;
Joo-Hang Kim

Publication type:

Article

The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 611, doi. 10.1007/s00280-010-1302-4

By:

Sonnemann, Jürgen;
Greßmann, Stephanie;
Becker, Sabine;
Wittig, Susan;
Schmudde, Mareike;
Beck, James F.

Publication type:

Article

Influence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapy.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 501, doi. 10.1007/s00280-009-1187-2

By:

Nogueira, Augusto;
Catarino, Raquel;
Coelho, Ana;
Araújo, António;
Gomes, Mónica;
Medeiros, Rui

Publication type:

Article

Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 455, doi. 10.1007/s00280-009-1181-8

By:

Ying Wang;
Rishi, Arun K.;
Puliyappadamba, Vineshkumar T.;
Sharma, Sunita;
Huanjie Yang;
Tarca, Adi;
Q. Ping Dou;
Lonardo, Fulvio;
Ruckdeschel, John C.;
Pass, Harvey I.;
Wali, Anil

Publication type:

Article

Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 585, doi. 10.1007/s00280-009-1200-9

By:

Nathwani, Seema-Maria;
Butler, Stephen;
Fayne, Darren;
McGovern, Naomi N.;
Sarkadi, Balazs;
Meegan, Mary J.;
Lloyd, David G.;
Campiani, Giuseppe;
Lawler, Mark;
Williams, D. Clive;
Zisterer, Daniela M.

Publication type:

Article

Anemia response and safety to epoetin-beta treatment in patients with neoadjuvant therapy prior to primary digestive tract tumor surgery.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 567, doi. 10.1007/s00280-009-1197-0

By:

Gómez, Antonio;
Salgado, Mercedes;
Valladares-Ayerbes, Manuel;
Jorge, Mónica;
Carballo, Ana;
Candamio, Sonia;
Castro, Enrique;
López, Rafael

Publication type:

Article

A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 535, doi. 10.1007/s00280-009-1194-3

By:

Massey, Andrew J.;
Williamson, Douglas S.;
Browne, Helen;
Murray, James B.;
Dokurno, Pawel;
Shaw, Terry;
Macias, Alba T.;
Daniels, Zoe;
Geoffroy, Stephanie;
Dopson, Melanie;
Lavan, Paul;
Matassova, Natalia;
Francis, Geraint L.;
Graham, Christopher J.;
Parsons, Rachel;
Yikang Wang;
Padfield, Antony;
Comer, Mike;
Drysdale, Martin J.;
Wood, Mike

Publication type:

Article

Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 559, doi. 10.1007/s00280-009-1196-1

By:

Loupakis, Fotios;
Masi, Gianluca;
Fornaro, Lorenzo;
Vasile, Enrico;
Allegrini, Giacomo;
Fontana, Eloise;
Granetto, Cristina;
Salvatore, Lisa;
Mentuccia, Lucia;
Andreuccetti, Michele;
Cortesi, Enrico;
Merlano, Marco;
Cascinu, Stefano;
Falcone, Alfredo

Publication type:

Article

MDR1 C2005T polymorphism changes substrate specificity.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 617, doi. 10.1007/s00280-010-1308-y

By:

Lijuan Liu;
Lan Fan;
Xiangdong Peng;
Dongli Hu;
Honghao Zhou

Publication type:

Article

Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 605, doi. 10.1007/s00280-010-1298-9

By:

Bouchahda, Mohamed;
Karaboué, Abdoulaye;
Saffroy, Raphaël;
Innominato, Pasquale;
Gorden, Lee;
Guettier, Catherine;
Adam, René;
Lévi, Francis

Publication type:

Article

Bendamustine: something old, something new.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 413, doi. 10.1007/s00280-010-1317-x

By:

Tageja, Nishant;
Nagi, Jasdeepa

Publication type:

Article

Cellular and molecular mechanisms for the synergistic cytotoxicity elicited by oxaliplatin and pemetrexed in colon cancer cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 547, doi. 10.1007/s00280-009-1195-2

By:

Nannizzi, Sara;
Veal, Gareth J.;
Giovannetti, Elisa;
Mey, Valentina;
Ricciardi, Simona;
Ottley, Christopher J.;
Del Tacca, Mario;
Danesi, Romano

Publication type:

Article

Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment.

Published in:

2010

By:

Jiayu Wang;
Ying Fan;
Xu, Binghe

Publication type:

Report

A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 527, doi. 10.1007/s00280-009-1193-4

By:

Nakachi, Kohei;
Furuse, Junji;
Kinoshita, Taira;
Kawashima, Mitsuhiko;
Ishii, Hiroshi;
Ikeda, Masafumi;
Mitsunaga, Shuichi;
Shimizu, Satoshi

Publication type:

Article

Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 3, p. 575, doi. 10.1007/s00280-009-1198-z

By:

Reinicke, Kathryn E.;
Kuffel, Mary J.;
Goetz, Matthew P.;
Ames, Matthew M.

Publication type:

Article